| scholarly article | Q13442814 |
| P356 | DOI | 10.2967/JNUMED.115.170027 |
| P698 | PubMed publication ID | 27151986 |
| P50 | author | Mark A. Mintun | Q43463865 |
| P2093 | author name string | Michael D Devous | |
| William R Shankle | |||
| Adam J Schwarz | |||
| Sergey Shcherbinin | |||
| Abhinay Joshi | |||
| Matthew Flitter | |||
| Michael Navitsky | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| mild cognitive impairment | Q1472703 | ||
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 1535-1542 | |
| P577 | publication date | 2016-05-05 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease | |
| P478 | volume | 57 |
| Q53396939 | 18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal. |
| Q53787416 | 18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease. |
| Q90140035 | A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia |
| Q51320431 | A report of the automated radiosynthesis of the tau positron emission tomography radiopharmaceutical, [18 F]-THK-5351. |
| Q59612120 | An updated radiosynthesis of [F]AV1451 for tau PET imaging |
| Q95278331 | Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non-demented older adults |
| Q97644158 | Associations of [18F]-APN-1607 Tau PET Binding in the Brain of Alzheimer's Disease Patients With Cognition and Glucose Metabolism |
| Q89866666 | Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure |
| Q38739937 | Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease |
| Q58794612 | Disease-related patterns of in vivo pathology in Corticobasal syndrome |
| Q39021126 | Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. |
| Q92402592 | Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span |
| Q46075858 | Entorhinal tau pathology, episodic memory decline and neurodegeneration in aging. |
| Q88053895 | FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis |
| Q47684719 | Flortaucipir tau PET imaging in semantic variant primary progressive aphasia |
| Q90707233 | Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948 |
| Q48486327 | Increased basal ganglia binding of 18 F-AV-1451 in patients with progressive supranuclear palsy |
| Q42672461 | Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case |
| Q50061690 | MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([(18)F]-AV-1451) Binding. |
| Q48569440 | Optimization and Biodistribution of [(11)C]-TKF, An Analog of Tau Protein Imaging Agent [(18)F]-THK523. |
| Q89879475 | PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape |
| Q51766173 | PET imaging of tau protein targets: a methodology perspective. |
| Q47132556 | PET/MR Imaging: New Frontier in Alzheimer's Disease and Other Dementias |
| Q90658867 | Parametric methods for [18F]flortaucipir PET |
| Q37677783 | Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects. |
| Q47918679 | Preclinical Evaluation of (18)F-RO6958948, (11)C-RO6931643 and (11)C-RO6924963 as Novel Radiotracers for Imaging Aggregated Tau in AD with Positron Emission Tomography |
| Q40259674 | Quantification of Tau Load Using [(18)F]AV1451 PET. |
| Q39429271 | Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging. |
| Q90732288 | Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake |
| Q37739881 | Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition |
| Q47869824 | Spread of tau deposits: can we trust in vivo findings? |
| Q62830975 | Subthreshold Amyloid Predicts Tau Deposition in Aging |
| Q34680852 | Tau PET imaging: present and future directions |
| Q49295547 | Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms. |
| Q94393283 | Tau and Pet/Mri Imaging Biomarkers for Detecting and Diagnosing Early Dementia |
| Q38633337 | Tau-imaging in neurodegeneration |
| Q57183322 | The Role of Tau Imaging in Parkinsonian Disorders |
Search more.